Verification evidence is still being completed.
PDF / print export
Visiopharm
Horsholm, Denmark
- Verified lead
- Michael Grunkin
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Digital Pathology, Tissue Image Analysis, Precision Diagnostics, and Translational Biomarker Workflow
- Review cycle
- May 2026
- Full address
- Agern Alle 24, 2970 Horsholm, Denmark
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Visiopharm contact page confirming the Horsholm address.
- Editorial note
- Visiopharm is published because the official site confirms current leadership, Horsholm operating address, and a strong pathology and diagnostics platform with real life-science relevance.
Digital Pathology, Tissue Image Analysis, Precision Diagnostics, and Translational Biomarker Workflow
Official leadership disclosure, Official contact disclosure, Diagnostics-platform operating claim
Visiopharm is published because the official site confirms current leadership, Horsholm operating address, and a strong pathology and diagnostics platform with real life-science relevance.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Horsholm, Denmark
Visiopharm
Digital Pathology, Tissue Image Analysis, Precision Diagnostics, and Translational Biomarker Workflow · Commercial diagnostics platform
Visiopharm runs digital pathology, tissue image analysis, and diagnostics workflow support in Horsholm, Denmark.
- Lead
- Michael Grunkin (verified ↗)
- Address
- Agern Alle 24, 2970 Horsholm, Denmark (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Commercial diagnostics platform
- Capabilities
- Digital Pathology · Tissue Image Analysis · Diagnostics Workflow Support
- Founded
- 2002
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Michael Grunkin
CEO
Full addressAgern Alle 24, 2970 Horsholm, Denmark
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Commercial diagnostics platform
Horsholm, Denmark. Digital Pathology, Tissue Image Analysis, Precision Diagnostics, and Translational Biomarker Workflow. Review completed on 21 Mar 2026.
Danish corporate and diagnostics-software oversight
Official leadership disclosure, Official contact disclosure, Diagnostics-platform operating claim
Digital Pathology, Tissue Image Analysis, Precision Diagnostics, and Translational Biomarker Workflow
Visiopharm is published because the official site confirms current leadership, Horsholm operating address, and a strong pathology and diagnostics platform with real life-science relevance.
Editorial note
Visiopharm is published because the official site confirms current leadership, Horsholm operating address, and a strong pathology and diagnostics platform with real life-science relevance.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Digital Pathology
Tissue Image Analysis
Diagnostics Workflow Support
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Digital pathology platform
Image-analysis workflow
Translational diagnostics software systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Visiopharm located?
- Visiopharm operates from Agern Alle 24, 2970 Horsholm, Denmark, Horsholm, Denmark.
- Who runs Visiopharm?
- Visiopharm is led by Michael Grunkin, CEO. Verified 21 Mar 2026.
- What does Visiopharm do?
- Visiopharm runs digital pathology, tissue image analysis, and diagnostics workflow support in Horsholm, Denmark. Core capabilities: Digital Pathology, Tissue Image Analysis, Diagnostics Workflow Support.
Editorial context
Related technical briefs
Briefs that name Horsholm as a covered market or city.